A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans

Bernal FA, Schmidt TJ

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Leishmaniasis, a parasitic disease that represents a threat to the life of millions of people around the globe, is currently lacking effective treatments. We have previously reported on the antileishmanial activity of a series of synthetic 2-phenyl-2,3-dihydrobenzofurans and some qualitative structure–activity relationships within this set of neolignan analogues. Therefore, in the present study, various quantitative structure–activity relationship (QSAR) models were created to explain and predict the antileishmanial activity of these compounds. Comparing the performance of QSAR models based on molecular descriptors and multiple linear regression, random forest, and support vector regression with models based on 3D molecular structures and their interaction fields (MIFs) with partial least squares regression, it turned out that the latter (i.e., 3D-QSAR models) were clearly superior to the former. MIF analysis for the best-performing and statistically most robust 3D-QSAR model revealed the most important structural features required for antileishmanial activity. Thus, this model can guide decision-making during further development by predicting the activity of potentially new leishmanicidal dihydrobenzofurans before synthesis.

Details zur Publikation

FachzeitschriftMolecules
Jahrgang / Bandnr. / Volume28
Artikelnummer3399
StatusVeröffentlicht
Veröffentlichungsjahr2023
Sprache, in der die Publikation verfasst istEnglisch
DOI10.3390/molecules28083399
Link zum Volltexthttps://www.mdpi.com/1420-3049/28/8/3399
Stichwörter2-phenyl-2,3-dihydrobenzofurans; Leishmania; 3D-QSAR; QSAR; neolignan analogues

Autor*innen der Universität Münster

Bernal, Freddy Alexander
Professur für Pharmazeutische Biologie und Phytochemie (Prof. Schmidt)
Schmidt, Thomas
Professur für Pharmazeutische Biologie und Phytochemie (Prof. Schmidt)